diroximel fumarate

FDA Drug Profile — Vumerity

diroximel fumarate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Vumerity. Available dosage forms: capsule, capsule, delayed release.

Drug details

Generic Name
diroximel fumarate
Brand Names
Vumerity
Application Number
NDA211855
Sponsor
Biogen Inc.
NDC Codes
3
Dosage Forms
CAPSULE, CAPSULE, DELAYED RELEASE
Routes
ORAL
Active Ingredients
DIROXIMEL FUMARATE

Indications and Usage

1 INDICATIONS AND USAGE VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.